You are here

2019 EU DRUG MARKETS REPORT FROM THE EMCDDA AND EUROPOL
Year: 
2019
Go to Website

2019 EU Drug Markets Report from the EMCDDA and Europol

by
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and European Union Agency for Law Enforcement Cooperation (Europol)

This report provides a strategic and action-oriented analysis of the information available on Europe’s drug market. It uses a broad definition of the illicit drug market, encompassing the illicit production, trafficking, wholesale distribution and sale of controlled substances to the end user. The drug market has wide-ranging impacts on both security and public health, and therefore such a holistic and systemic perspective is important for the effective delivery and monitoring of drug control policy.

  • Health care professionals
  • NGOs
  • People living with HIV (PLHIV)
  • People who use drugs (PUD)
  • Policy makers
  • WHO European region
  • Care and support
  • Co-infections
  • Harm reduction
  • Human rights
  • Inequalities in health
  • Laws and regulations
  • Legislation
  • Migration
  • Monitoring and Evaluation
  • Policy
  • Stigma and discrimination
  • Treatment

Twitter News